Elucidating the Degradation Pathways of Human Insulin in the Solid State

Overview

Journal J Anal Test

Date 2024 Aug 26

PMID 39184306

Authors

Andrew Fagan

Lorraine M Bateman

Joseph P OShea

Abina M Crean

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s41664-024-00302-5.

References

Terryn H, Vanhelleputte J, Maquille A, Tilquin B . Chemical analysis of solid-state irradiated human insulin. Pharm Res. 2006; 23(9):2141-8. DOI: 10.1007/s11095-006-9053-y. View

Zapadka K, Becher F, Gomes Dos Santos A, Jackson S . Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface Focus. 2017; 7(6):20170030. PMC: 5665799. DOI: 10.1098/rsfs.2017.0030. View

Fosgerau K, Hoffmann T . Peptide therapeutics: current status and future directions. Drug Discov Today. 2014; 20(1):122-8. DOI: 10.1016/j.drudis.2014.10.003. View

Alliegro M . Effects of dithiothreitol on protein activity unrelated to thiol-disulfide exchange: for consideration in the analysis of protein function with Cleland's reagent. Anal Biochem. 2000; 282(1):102-6. DOI: 10.1006/abio.2000.4557. View

Wong C, Al-Salami H, Dass C . Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment. J Control Release. 2017; 264:247-275. DOI: 10.1016/j.jconrel.2017.09.003. View

Bouchard M, Zurdo J, Nettleton E, Dobson C, Robinson C . Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci. 2000; 9(10):1960-7. PMC: 2144465. DOI: 10.1110/ps.9.10.1960. View

Brange J, Langkjoer L . Insulin structure and stability. Pharm Biotechnol. 1993; 5:315-50. DOI: 10.1007/978-1-4899-1236-7_11. View

Leader B, Baca Q, Golan D . Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov. 2007; 7(1):21-39. DOI: 10.1038/nrd2399. View

Lai M, Topp E . Solid-state chemical stability of proteins and peptides. J Pharm Sci. 1999; 88(5):489-500. DOI: 10.1021/js980374e. View

10.

Haddadzadegan S, Dorkoosh F, Bernkop-Schnurch A . Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev. 2022; 182:114097. DOI: 10.1016/j.addr.2021.114097. View

11.

Sluzky V, Klibanov A, Langer R . Mechanism of insulin aggregation and stabilization in agitated aqueous solutions. Biotechnol Bioeng. 1992; 40(8):895-903. DOI: 10.1002/bit.260400805. View

12.

Bernstein G . Delivery of insulin to the buccal mucosa utilizing the RapidMist system. Expert Opin Drug Deliv. 2008; 5(9):1047-55. DOI: 10.1517/17425247.5.9.1047. View

13.

Jha S, Deepalakshmi P, Udgaonkar J . Characterization of deamidation of barstar using electrospray ionization quadrupole time-of-flight mass spectrometry, which stabilizes an equilibrium unfolding intermediate. Protein Sci. 2012; 21(5):633-46. PMC: 3403461. DOI: 10.1002/pro.2047. View

14.

Pikal M, Rigsbee D . The stability of insulin in crystalline and amorphous solids: observation of greater stability for the amorphous form. Pharm Res. 1997; 14(10):1379-87. DOI: 10.1023/a:1012164520429. View

15.

Tantipolphan R, Romeijn S, den Engelsman J, Torosantucci R, Rasmussen T, Jiskoot W . Elution behavior of insulin on high-performance size exclusion chromatography at neutral pH. J Pharm Biomed Anal. 2010; 52(2):195-202. DOI: 10.1016/j.jpba.2010.01.014. View

16.

Fogt Hjorth C, Norrman M, Wahlund P, Benie A, Petersen B, Jessen C . Structure, Aggregation, and Activity of a Covalent Insulin Dimer Formed During Storage of Neutral Formulation of Human Insulin. J Pharm Sci. 2016; 105(4):1376-86. DOI: 10.1016/j.xphs.2016.01.003. View

17.

Costantino H, Langer R, Klibanov A . Solid-phase aggregation of proteins under pharmaceutically relevant conditions. J Pharm Sci. 1994; 83(12):1662-9. DOI: 10.1002/jps.2600831205. View

18.

Cunningham S, Tanner D . A Review: The Prospect of Inhaled Insulin Therapy via Vibrating Mesh Technology to Treat Diabetes. Int J Environ Res Public Health. 2020; 17(16). PMC: 7460322. DOI: 10.3390/ijerph17165795. View

19.

Zhang L, Chou C, Moo-Young M . Disulfide bond formation and its impact on the biological activity and stability of recombinant therapeutic proteins produced by Escherichia coli expression system. Biotechnol Adv. 2011; 29(6):923-9. DOI: 10.1016/j.biotechadv.2011.07.013. View

20.

Zhao J, Xu G, Yao X, Zhou H, Lyu B, Pei S . Microneedle-based insulin transdermal delivery system: current status and translation challenges. Drug Deliv Transl Res. 2021; 12(10):2403-2427. PMC: 8528479. DOI: 10.1007/s13346-021-01077-3. View